bpc 157 in center city BPC-157 Injectable Peptide for Healing & Recovery BPC-157 Peptide Therapy in Jacksonville

OASIS trials: establishing effective doses Phase 2 OASIS 1 findings: Tested multiple dose levels: 0.3mg, 0.6mg, 1.2mg, 2.4mg, 4.5mg weekly Duration: 26 weeks Primary endpoint: Weight loss at each dose Dose-response results: 0.3mg weekly: ~4% body weight loss 0.6mg weekly: ~6% body weight loss 1.2mg weekly: ~8% body weight loss 2.4mg weekly: ~10% body weight loss 4.5mg weekly: ~12% body weight loss Key insight: Clear dose-response relationship

COVID-19 patients with mild symptoms typically feel better after one to two weeks

Kaminska B

& Detamore, M

10.1016/j.chembiol.2003.10.003 31 MatsuiJ.HaqueA.HussD.MessanaE.AlosiJ.RobersonD.et al

Nicotinamide (Vitamin B3) Supports cellular energy production, nervous system function, and skin health